CLASS ACTION UPDATE for GTT, TWOU and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders – Yahoo Finance

NEW YORK, NY / ACCESSWIRE / September 20, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

GTT Communications, Inc. (GTT)

Lawsuit on behalf of: investors who purchased February 26, 2018 - July 1, 2019Lead Plaintiff Deadline : September 30, 2019TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/gtt-communications-inc-loss-form?prid=3618&wire=1.

According to the filed complaint, during the class period, GTT Communications, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) following GTT's acquisition of Interoute Communications Holdings S.A., there were delays in migrating Interoute's legacy systems and processes into GTT's client management database system; (2) Interoute had made a strategic priority shift to sell cloud services that was a higher percentage of Interoute's sales in the two years leading up to the acquisition; (3) a material percentage of the Interoute sales representatives were not productive at selling GTT's core cloud networking services; (4) GTT was unable to yield as many Interoute salespeople because Interoute had hired many sales people focused on cloud services and allowed underperforming sales representatives to remain at Interoute; and (5) as a result of the foregoing, Defendants' public statements were materially false and/or misleading and/or lacked a reasonable basis.

2U, Inc. (TWOU)

Lawsuit on behalf of: investors who purchased February 26, 2018 - July 30, 2019Lead Plaintiff Deadline : October 7, 2019TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/2u-inc-loss-form?prid=3618&wire=1.

According to the filed complaint, during the class period, 2U, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) 2U's business model was fundamentally flawed because the Company's costs were growing disproportionately as it grew in size and complexity; (b) 2U could not take advantage of the promised economies of scale because its costs to attract each marginal student were actually increasing, not decreasing, as represented; (c) 2U was facing heightened competitive headwinds as alternative offerings flooded the marketplace and universities developed online courses in-house; (d) 2U's growth rate in student enrollment was decelerating and was poised to decline as the Company reached market saturation; (e) 2U's growth strategy was unsustainable, as the Company faced accelerating costs and had insufficient capital to achieve positive cash flows, improve margins or continue its revenue growth; and (f) as a result of (a)-(e), above, Defendants lacked any reasonable basis to issue 2U's projections and financial forecasts.

Sarepta Therapeutics, Inc. (SRPT)

Lawsuit on behalf of: investors who purchased September 6, 2017 - August 19, 2019Lead Plaintiff Deadline : October 29, 2019TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sarepta-therapeutics-inc-loss-form?prid=3618&wire=1.

According to the filed complaint, during the class period, Sarepta Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) golodirsen, Sarepta's drug for the treatment of Duchenne muscular dystrophy, posed significant safety risks to patients; (ii) consequently, the New Drug Application package for golodirsen's accelerated approval was unlikely to receive Food and Drug Administration approval; and (iii) as a result, Sarepta's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

Story continues

Read this article:
CLASS ACTION UPDATE for GTT, TWOU and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - Yahoo Finance